Anlon Healthcare, founded in 2013, is a pharmaceutical company based in Rajkot, Gujarat. The company began its manufacturing operations in 2017 and is engaged in the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and nutraceutical compounds. With a focus on quality and compliance, the company operates a single manufacturing facility that is ISO 9001:2015, GMP, and WHO-GMP certified. Anlon Healthcare serves pharmaceutical companies across India and exports to select international markets.
IPO schedule
Issue open date
2025-08-26
Issue close date
2025-08-29
UPI mandate deadline
2025-08-29 (5 PM)
Allotment finalization
2025-09-01
Refund initiation
2025-09-02
Share credit
2025-09-02
Listing date
2025-09-03
Mandate end date
2025-09-15
Lock-in end date for anchor investors (50%)
2025-10-01
Lock-in end date for anchor investors (remaining)
2025-11-30
Issue size
Funds Raised in the IPO
Amount
Overall
₹121.03 crores
Fresh Issue
₹121.03 crores
Financials
Financial Year Ended
March 2022
March 2023
March 2024
January 2025
Total Assets
84.97
111.54
128.00
160.95
Revenue
57.53
113.12
66.69
77.37
Profit After Tax
0.10
5.82
9.65
11.96
Utilisation of proceeds
Purpose
INR crores (%)
Capital expenditure for expansion
30.71 (25.37%)
Repayment/pre-payment, in full or in part, of outstanding borrowings
5.00 (4%)
Working capital requirements
43.15 (35.65%)
General corporate purposes and miscellaneous
42.17 (35%)
Strengths
Diverse product portfolio with scalable business operations.
Experienced promoters and competent management team.
High entry barriers due to strict approval standards.
In-house testing ensures consistent quality and compliance.
Emphasis on Quality, Environment, Health, and Safety (QEHS).
Risks
High dependency on single manufacturing unit in Rajkot, Gujarat.
Revenue concentration from top few pharmaceutical industry customers.
Limited experience in complex pharma intermediates manufacturing.
Heavy reliance on select suppliers from western India.
Delay in regulatory approvals can halt operations and revenue.